Q-omics provides the consensus-scored ZBTB20-AS2 profile across patient tissues and cancer cell-line models. ZBTB20-AS2 expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in BLCA. Additionally, ZBTB20-AS2 RNA expression shows 10,143 significant gene co-expression associations, with the highest sampling consensus in BRCA. Together, these results highlight BLCA, and BRCA as cancer lineages where ZBTB20-AS2 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for ZBTB20-AS2 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes ZBTB20-AS2 survival associations across molecular data types. ZBTB20-AS2 RNA expression shows survival associations in the most cancer types (8). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

ZBTB20-AS2 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	8	BLCA (171)	view →

This table ranks reproducible ZBTB20-AS2 RNA expression–survival associations across cancer types. High ZBTB20-AS2 expression shows unfavorable associations in BLCA, READ, LIHC, KIRP and ESCA, but favorable associations in STAD. The BLCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify BLCA as the clearest survival context for ZBTB20-AS2 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	II,III,IV	0.099	0.619	<.001	171	view →
STAD	OS	Median	All	0.762	0.645	.008	51	view →
READ	DFS	Tertile	III,IV	0.255	0.757	.008	45	view →
LIHC	OS	Tertile	All	0.031	0.775	<.001	45	view →
KIRP	DFS	Tertile	II,III,IV	0.122	0.626	.032	18	view →
ESCA	OS	Quartile	II,III,IV	0.300	0.512	.017	11	view →

Pink = unfavorable, green = favorable. all 8 lineages →

ZBTB20-AS2-BLCA (DFS)

Kaplan–Meier survival curve for ZBTB20-AS2 RNA expression in BLCA: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with ZBTB20-AS2 in patient tissues and cancer cell lines. In patient samples, ZBTB20-AS2 shows the broadest associations at the RNA and protein expression levels, with BRCA recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	10,143	BRCA (3896)	view →
Protein (mass-spec)	9,347	LUAD (3288)	view →